Online citations, reference lists, and bibliographies.
← Back to Search

Chemoprevention Of Colorectal Cancer.

Bryson W. Katona, J. Weiss
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Although colorectal cancer (CRC) screening has reduced the incidence and mortality from CRC, chemoprevention strategies have potential to further reduce CRC incidence and mortality. Chemoprevention agents might be used for average-risk as well as high-risk groups, and to prevent colorectal cancer recurrence after therapy. CRC chemoprevention agents that have been studied include aspirin, non-aspirin non-steroidal anti-inflammatory drugs, statins, agents that target metabolic pathways, and vitamins and minerals. We review the prospect of chemoprevention of CRC, results from preclinical and human studies, challenges, and future directions.
This paper references
10.1056/NEJM199509073331001
Aspirin and the risk of colorectal cancer in women.
E. Giovannucci (1995)
10.7326/0003-4819-159-2-201307160-00002
Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial
N. Cook (2013)
10.1016/S0140-6736(07)60747-8
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
E. Flossmann (2007)
A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women.
W. Zheng (1998)
10.1016/S1470-2045(12)70112-2
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
A. M. Algra (2012)
10.1056/NEJMOA061652
Celecoxib for the prevention of colorectal adenomatous polyps.
N. Arber (2006)
Approaches to prevention of epithelial cancer during the preneoplastic period.
M. Sporn (1976)
10.1007/s10552-015-0686-1
Colorectal polyp prevention by daily aspirin use is abrogated among active smokers
David A. Drew (2015)
10.1161/CIRCULATIONAHA.110.963843
Aspirin: A Historical and Contemporary Therapeutic Overview
V. Fuster (2011)
10.1016/j.canep.2018.11.002
Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis.
Tanja Tomić (2019)
10.1158/1940-6207.CAPR-19-0023
No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial
Audrey H Calderwood (2019)
10.1016/j.toxlet.2010.09.010
Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells.
Xufeng Qi (2010)
10.1053/j.gastro.2018.07.017
Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.
T. Levin (2018)
10.1093/JNCI/DJK132
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
E. Jacobs (2007)
10.1016/0169-5002(94)92177-6
The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
G. Omenn (1994)
Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.
D. Corpet (2003)
10.1158/1055-9965.EPI-13-0196
The Use of Metformin and Colorectal Cancer Incidence in Patients with Type II Diabetes Mellitus
Brielan B. Smiechowski (2013)
10.1002/mc.20637
Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase
K. Hosono (2010)
10.1200/JCO.2011.35.7566
Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies.
Yanlei Ma (2011)
10.1093/CARCIN/22.7.1061
HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2.
A. Waechtershaeuser (2001)
10.1159/000203636
The Long-Term Use of Statins Is Associated with a Decreased Incidence of Adenomatous Colon Polyps
A. Siddiqui (2009)
10.1023/A:1010062929140
Molecular Nature of the Vitamin D Receptor and its Role in Regulation of Gene Expression
P. Jurutka (2004)
10.1007/s10552-010-9549-y
Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies
Y. Park (2010)
Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012.
Q. Gu (2014)
10.1056/NEJMOA043792
Statins and the risk of colorectal cancer.
J. Poynter (2005)
10.2143/AC.64.3.2038016
Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity
M. Ebrahimi (2009)
10.1007/s00125-009-1440-6
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. Currie (2009)
10.1371/journal.pone.0125421
Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study
C. Lin (2015)
10.1053/GAST.2002.31890
Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
M. Cruz-Correa (2002)
10.1111/jgh.13639
Metformin use and the risk of colorectal adenoma: A systematic review and meta‐analysis
Y. Jung (2017)
10.1111/j.1463-1318.2010.02289.x
Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta‐analysis
D. Papaioannou (2011)
10.1053/J.GASTRO.2006.08.079
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
J. Baron (2006)
10.1056/NEJMoa1207756
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
X. Liao (2012)
10.1007/978-0-387-46401-5_10
Molecular targets of curcumin.
J. Lin (2007)
10.7326/M15-2117
Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force
Jessica Chubak (2016)
10.1016/j.cct.2016.10.004
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
C. Coyle (2016)
10.1530/EJE-12-0369
Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan.
C. Tseng (2012)
10.1038/srep12044
Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials
Tingting Qin (2015)
10.7326/0003-4819-128-9-199805010-00003
Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study
Til Sturmer (1998)
Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
M. J. Reeves (1996)
10.1016/S0140-6736(10)61543-7
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
P. Rothwell (2010)
10.1200/JCO.2006.06.3560
Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
S. Bonovas (2006)
10.1007/s11745-999-0480-7
Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29
Rosemary G. Clarke (1999)
10.1056/NEJMOA021735
A randomized trial of aspirin to prevent colorectal adenomas.
J. Baron (2003)
10.2337/dc08-2175
New Users of Metformin Are at Low Risk of Incident Cancer
G. Libby (2009)
10.1093/carcin/bgp152
Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci.
Gillian Lindzon (2009)
10.1207/S15327914NC431_4
Dietary Calcium and Vitamin D Intake and Risk of Colorectal Cancer: A Prospective Cohort Study in Women
P. Terry (2002)
10.7326/M14-0198
Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement.
V. Moyer (2014)
10.7326/0003-4819-121-4-199408150-00001
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
E. Giovannucci (1994)
10.1080/07315724.2003.10719272
Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
S. Padayatty (2003)
10.1371/journal.pone.0152402
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
P. Elwood (2016)
10.7326/M16-0577
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
K. Bibbins-Domingo (2016)
10.1002/ijc.10138
Dietary intake of folic acid and colorectal cancer risk in a cohort of women
P. Terry (2002)
10.1056/NEJM199312303292701
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.
S. Winawer (1993)
10.1016/S0140-6736(11)61125-2
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial
R. Bulbulia (2011)
10.1158/1940-6207.CAPR-10-0028
Inhibition of Intestinal Polyp Formation by Pitavastatin, a HMG-CoA Reductase Inhibitor
Naoya Teraoka (2011)
10.1056/NEJMoa1805819
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
J. McNeil (2018)
10.1016/S0140-6736(11)61049-0
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
J. Burn (2011)
Ornithine decarboxylase activity in the rat and human colon.
J. Rozhin (1984)
10.1093/jnci/djv170
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
Driss Ait Ouakrim (2015)
10.1056/NEJMOA061355
Celecoxib for the prevention of sporadic colorectal adenomas.
M. Bertagnolli (2006)
10.1056/NEJM199810293391803
Aberrant Crypt Foci of the Colon as Precursors of Adenoma and Cancer
T. Takayama (1998)
10.1038/nature11465
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
S. Grivennikov (2012)
10.1038/nature04808
IL-23 promotes tumour incidence and growth
John L. Langowski (2006)
10.1056/NEJMOA012015
Primary chemoprevention of familial adenomatous polyposis with sulindac.
F. Giardiello (2002)
10.1056/NEJMOA050405
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
S. Solomon (2005)
10.1186/1471-2407-11-20
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee (2010)
10.1007/BF02257810
Folate supplementation and adenomatous colonic polyps
G. Paspatis (1994)
10.1017/S0029665199000944
Vitamin A and immunity to viral, bacterial and protozoan infections.
R. Semba (1999)
10.1016/j.gie.2008.12.060
Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.
A. Gupta (2009)
10.7326/M15-0039
Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk
S. Friis (2015)
10.1158/1078-0432.CCR-10-2395
Randomized Double-Blind Trial of Sulindac and Etodolac to Eradicate Aberrant Crypt Foci and to Prevent Sporadic Colorectal Polyps
T. Takayama (2011)
10.1016/j.cgh.2012.08.037
Statins and colorectal cancer.
P. Lochhead (2013)
10.1016/j.niox.2014.04.006
Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
W. Elsheikh (2014)
10.1158/1055-9965.EPI-03-0080
Reported Use of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Was Not Associated with Reduced Recurrence of Colorectal Adenomas
J. Wei (2005)
A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
Tetsuro Higuchi (2003)
10.1007/s40495-016-0046-1
Current Status of Folic Acid Supplementation on Colorectal Cancer Prevention
Y. Kim (2016)
10.7326/M15-2129
Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force
S. Dehmer (2016)
10.1124/pr.111.004994
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
P. Gazzerro (2012)
10.1158/1055-9965.EPI-17-0573
Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH
J. Wang (2018)
10.1002/ijc.20648
Folate intake and colorectal cancer risk: A meta‐analytical approach
M. A. Sanjoaquin (2005)
10.1093/CARCIN/20.4.645
Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon.
P. Latham (1999)
10.1136/gut.2010.233718
Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer
A. Cockbain (2011)
10.1056/NEJMOA021633
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
R. Sandler (2003)
10.7326/0003-4819-139-1-200307010-00013
Routine Vitamin Supplementation To Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale
U. P. S. T. Force (2003)
10.1158/1940-6207.CAPR-11-0166
Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention
S. Fischer (2011)
10.1016/S0016-5085(03)00887-4
Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.
R. Benamouzig (2003)
10.1080/01635581.2013.804101
Long-Chain Omega-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer
E. Kantor (2014)
10.1002/cam4.306
Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case–control study
Majken Cardel (2014)
10.1001/jamaoncol.2017.2752
Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer
L. Emilsson (2018)
10.1111/j.1349-7006.2008.00933.x
Metformin suppresses intestinal polyp growth in ApcMin/+ mice
A. Tomimoto (2008)
10.1517/14740331003662620
Statin use and cancer risk: a comprehensive review
D. Boudreau (2010)
10.1002/prp2.224
Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH‐naproxen (AVT‐219) a dual NO‐ and H2S‐releasing hybrid
Mitali Chattopadhyay (2016)
10.1016/j.ejca.2008.06.025
Statins and cancer: A systematic review and meta-analysis.
J. Kuoppala (2008)
10.1093/JNCI/94.6.437
Calcium intake and risk of colon cancer in women and men.
K. Wu (2002)
10.1158/1940-6207.CAPR-11-0106
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis
J. Burn (2011)
10.1016/j.clnu.2017.10.010
Folic acid intake and folate status and colorectal cancer risk: A systematic review and meta-analysis.
S. Moazzen (2018)
10.1056/NEJM200006293422603
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
G. Steinbach (2000)
10.1093/JNCI/85.15.1220
Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
P. Gann (1993)
10.1158/1055-9965.EPI-13-0429
Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis
S. Singh (2013)
10.1371/journal.pone.0029849
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
J. Emberson (2012)
10.1056/NEJMoa1809944
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
J. Manson (2019)
10.1093/JNCI/90.1.57
Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas.
J. Baron (1998)
10.1056/NEJMoa1301969
Long-term colorectal-cancer incidence and mortality after lower endoscopy.
R. Nishihara (2013)
10.1136/gutjnl-2011-300113
Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
R. Benamouzig (2011)
10.1530/ERC-12-0381
Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
Carlien Leyssens (2013)
10.1038/nrc3691
The role of vitamin D in reducing cancer risk and progression
D. Feldman (2014)
10.1016/0304-3835(87)90157-1
Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings.
R. P. Bird (1987)
10.1001/JAMA.297.21.2351
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
B. Cole (2007)
10.1158/1940-6207.CAPR-08-0042
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
F. Meyskens (2008)
10.1001/jamaoncol.2017.5431
Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial
N. Samadder (2018)
10.1093/AJE/KWH066
Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review.
L. Sharp (2004)
10.1111/apt.13857
Systematic review with meta‐analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention
L. Emilsson (2017)
10.1006/ABBI.2000.2149
Antioxidant and prooxidant properties of carotenoids.
A. Young (2001)
10.1056/NEJMOA050493
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
R. Bresalier (2005)
Proceedings: Prostaglandins in human colonic carcinoma.
Cove-Smith (1975)
10.1200/JCO.2005.08.097
Colorectal Cancer Prevention
E. Hawk (2005)
10.7326/0003-4819-146-5-200703060-00010
Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
A. Rostom (2007)
10.1172/JCI13505
Role of AMP-activated protein kinase in mechanism of metformin action.
G. Zhou (2001)
10.1001/JAMA.294.1.47
Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial
N. Cook (2005)
10.1186/s12876-016-0494-4
Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial
C. Burke (2016)
10.1158/1940-6207.CAPR-09-0271
Statin Use and Colorectal Adenoma Risk: Results from the Adenoma Prevention with Celecoxib Trial
M. Bertagnolli (2010)
10.1056/NEJM199901143400204
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
J. Baron (1999)
10.1016/S0090-6980(74)80055-9
Prostaglandins and cancer: an update.
B. Jaffe (1974)
10.1158/1940-6207.CAPR-10-0007
Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer
S. Lipkin (2010)
10.1158/1055-9965.EPI-17-0424
A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus
M. Bradley (2018)
10.1093/CARCIN/13.4.541
Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis.
P. Craven (1992)
10.1016/S1470-2045(15)00565-3
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
T. Higurashi (2016)
10.1002/cncr.29165
Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population
Amikar Sehdev (2015)
10.1016/S0899-9007(00)00347-6
Vitamin A and cancer.
R. Niles (2000)
10.1023/A:1022591007673
Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States)
M. McCullough (2004)
10.1136/gut.2009.200642
Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis
N. J. West (2010)
10.1001/jamaoncol.2015.6396
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
Yin Cao (2016)
10.1093/ajcn/53.4.1050S
Protective role of vitamin E in biological systems.
L. Packer (1991)
10.1056/NEJMoa1300720
Long-term mortality after screening for colorectal cancer.
A. Shaukat (2013)
10.7326/0003-4819-154-1-201101040-00004
Protection From Colorectal Cancer After Colonoscopy
H. Brenner (2011)
10.1158/1940-6207.CAPR-08-0043
Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention
Peter M. Lance (2008)
10.1056/NEJM199305063281805
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
F. Giardiello (1993)
10.1158/0008-5472.CAN-05-4619
Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
M. Swamy (2006)
10.1093/jn/134.12.3463S
Vitamin D and colon carcinogenesis.
D. Harris (2004)
10.1158/1055-9965.EPI-11-0992-T
Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case–Control Analysis
M. Bodmer (2011)
10.1093/JN/130.2.129
Folate and carcinogenesis: an integrated scheme.
S. W. Choi (2000)
10.1093/CARCIN/9.1.187
Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3.
B. Pence (1988)
10.1001/jamaoncol.2016.5917
Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial
E. Barry (2017)
10.1016/S0016-5085(98)70305-1
Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin.
C. Barnes (1998)
10.1056/NEJMoa0801297
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
J. Burn (2008)
10.1001/jama.2016.2522
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
N. J. Samadder (2016)
10.1093/jnci/djn485
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
B. Cole (2009)
10.1200/JCO.2014.59.7633
Metastatic colorectal cancer: current state and future directions.
M. Fakih (2015)
10.1093/CARCIN/14.8.1493
Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats.
B. Reddy (1993)
10.1111/j.1365-2036.2006.02970.x
Meta‐analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma
G. Bjelakovic (2006)
10.1056/NEJMoa1803955
Effect of Aspirin on All‐Cause Mortality in the Healthy Elderly
J. McNeil (2018)
10.1038/nrc.2016.4
Aspirin and colorectal cancer: the promise of precision chemoprevention
David A. Drew (2016)
10.1002/ijc.22366
Statins and risk of cancer: A systematic review and metaanalysis
D. Browning (2007)
10.1001/JAMA.295.1.74
Statins and cancer risk: a meta-analysis.
K. M. Dale (2006)
10.1186/1471-2407-8-237
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
R. Harris (2007)
10.18632/oncotarget.13762
Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
Feifei Liu (2017)
10.1038/sj.onc.1211024
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben-Sahra (2008)
10.1186/s13063-016-1744-z
ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial
David A. Drew (2017)
10.1158/1940-6207.CAPR-11-0107
Nonsteroidal Anti-inflammatory Drug Use and Risk of Adenomatous and Hyperplastic Polyps
H. Murff (2011)
10.1158/1055-9965.EPI-15-0085
Colorectal Cancer Risk Following Adenoma Removal: A Large Prospective Population-Based Cohort Study
H. Coleman (2015)
10.1111/j.1365-2036.2010.04238.x
Meta‐analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer
C. Carroll (2010)
10.2174/15680266113136660068
Use of biguanides and the risk of colorectal cancer: a register-based cohort study.
L. M. Knapen (2013)
10.1136/gutjnl-2016-312712
Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study
C. Doubeni (2018)
The Effect of α-Tocopherol and β-Carotene Supplementation on Colorectal Adenomas in Middle-Aged Male Smokers
N. Malila (1999)
The statins as anticancer agents.
K. Chan (2003)
10.1136/gutjnl-2017-315242
Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial
S. Crockett (2018)
10.1001/jama.2015.1815
Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
H. Nan (2015)
10.1093/JNCI/DJI375
Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
S. Larsson (2005)
10.1007/s11886-017-0814-5
Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease
S. Ross (2017)
10.1136/gutjnl-2014-307235
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis
P. Lynch (2015)
10.1093/IJE/DYM193
Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.
G. Kune (1988)
10.1007/s10620-014-3444-4
The Molecular Pathogenesis of Colorectal Cancer and Its Potential Application to Colorectal Cancer Screening
W. Grady (2014)
10.1371/journal.pone.0147289
Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis
M. Paul-Clark (2016)
10.1053/J.GASTRO.2007.09.035
Aspirin dose and duration of use and risk of colorectal cancer in men.
A. Chan (2008)
10.1053/j.gastro.2018.05.031
Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis.
M. Cruz-Correa (2018)
10.1074/jbc.M602859200
The Adenomatous Polyposis Coli Tumor Suppressor Gene Regulates Expression of Cyclooxygenase-2 by a Mechanism That Involves Retinoic Acid*
Annie L Eisinger (2006)
10.1158/1940-6207.CAPR-11-0113
Statin Use and Colorectal Cancer Risk According to Molecular Subtypes in Two Large Prospective Cohort Studies
J. Lee (2011)
10.1136/gutjnl-2013-305827
The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial
H. Ishikawa (2014)
10.1093/jnci/djm286
The association between statins and cancer incidence in a veterans population.
W. Farwell (2008)
10.1056/nejm199404143301501
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.
O. Heinonen (1994)
10.1016/j.cgh.2018.12.012
Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer.
A. Rodríguez-Miguel (2018)
10.1016/S0140-6736(18)31924-X
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
J. Gaziano (2018)
10.1056/NEJMOA067208
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
A. Chan (2007)
10.1056/NEJMOA065994
Long-term follow-up of the West of Scotland Coronary Prevention Study.
I. Ford (2007)
10.1007/BF02053860
Folate status and adenomatous colonic polyps
G. Paspatis (1995)
10.1097/CEJ.0b013e3282b721fe
Statins and cancer: a meta-analysis of case–control studies
M. Taylor (2008)
10.1158/1940-6207.CAPR-11-0222
Combination of Atorvastatin with Sulindac or Naproxen Profoundly Inhibits Colonic Adenocarcinomas by Suppressing the p65/β-Catenin/Cyclin D1 Signaling Pathway in Rats
N. Suh (2011)
10.7326/0003-4819-129-7-199810010-00002
Multivitamin Use, Folate, and Colon Cancer in Women in the Nurses' Health Study
E. Giovannucci (1998)
10.1177/002215540004800503
Immunocytochemical Localization of the Extracellular Calcium-Sensing Receptor in Normal and Malignant Human Large Intestinal Mucosa
Y. Sheinin (2000)
10.1016/S0140-6736(18)31775-6
Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial
M. Hull (2018)
10.1146/annurev-nutr-071811-150740
Selenoproteins and cancer prevention.
C. Davis (2012)
Aberrant crypts: potential preneoplastic lesions in the murine colon.
E. McLellan (1988)
10.3748/WJG.14.4492
Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
R. Jaszewski (2008)
10.1253/CIRCJ.CJ-10-1281
Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.
K. Saku (2011)
10.1186/1745-6215-12-261
The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial
R. Ali (2011)
10.7326/0003-4819-140-3-200402030-00006
A Prospective Study of Aspirin Use and the Risk for Colorectal Adenoma
A. Chan (2004)
10.1002/pds.3823
No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK
B. Kowall (2015)
10.3390/ijms19082332
Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives
A. Mohammed (2018)
10.1007/s00384-011-1232-6
IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma
F. Lan (2011)
10.1016/0027-5107(93)90036-F
Role of calcium in colon cancer prevention: experimental and clinical studies.
B. Pence (1993)
10.1016/J.CCR.2005.08.008
The Akt-mTOR tango and its relevance to cancer.
N. Hay (2005)
10.1016/S0140-6736(11)61720-0
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
P. Rothwell (2012)
10.1053/J.GASTRO.2007.10.014
Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
R. Logan (2008)
10.1073/PNAS.94.2.657
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.
R. Coffey (1997)
10.1158/1940-6207.CAPR-08-0206
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
M. Bertagnolli (2009)
10.1158/1940-6207.CAPR-16-0194
A Way Forward for Cancer Chemoprevention: Think Local
Luai Al Rabadi (2016)
10.1056/NEJMoa1500409
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.
J. Baron (2015)
10.3945/ajcn.2009.28319
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.
K. Wu (2009)
10.2337/dc11-0512
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes
Zhi-Jiang Zhang (2011)
10.1056/NEJMOA055222
Calcium plus vitamin D supplementation and the risk of colorectal cancer.
J. Wactawski-Wende (2006)
10.1093/JN/131.1.161S
Vitamin E: mechanisms of action as tumor cell growth inhibitors.
K. Kline (2001)
10.1056/NEJMoa1114635
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
R. Schoen (2012)
10.1053/j.gastro.2008.02.012
Chemoprevention of colorectal neoplasia: the potential for personalized medicine.
N. Arber (2008)
10.1053/JPSU.2001.25784
The management of prenatally diagnosed choledochal cysts.
T. MacKenzie (2001)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar